VALUE OF MULTI-PARAMETRIC MRI, TOTAL PSA INDEX AND FREE/TOTAL PSA RATIO IN DIAGNOSIS OF PROSTATE CANCER AT HUU NGHI HOSPITAL IN 2023

Thị Ngọc Mai Trần, Đăng Khoa Trần

Main Article Content

Abstract

Objectives: Evaluate the effectiveness of detecting prostate cancer lesions using multiparametric magnetic resonance imaging (mp-MRI) technique and PSA indices. Subjects and methods: Retrospective study on 56 patients with suspected prostate cancer mp- MRI, prostate biopsy at Huu Nghi hospital from January 2022 to January 2023 satisfied the patient selection and exclusion criteria, with total PSA index, free/total PSA ratio, combine methods and compare with pathology results on transrectal prostate biopsy. Results: Average age is 72,58 ± 6.89, average prostate volume is 55,47±31,81ml, average total PSA concentration is 35.84±28 ng/ml, free/total ratio PSA mean was 0.16±0.06. The number of prostate cancer patients is 47, accounting for 83,9%. The PIRADS classification with the highest incidence is PIRADS 4 and 5. Applying the free/total PSA index (cut off point is 0,15) and combining the total PSA index with mp MRI has high value in diagnosing prostate cancer with AUC of 0,85 and 0,82. Conclusion: Using mp-MRI combined with total PSA has high diagnostic value in prostate cancer, the free/total ratio with a threshold value of 0.15 has a high value to suggest prostate cancer.

Article Details

References

1. Bıçaklıoğlu, Fatih, et al. "The Predictive Ability of Prostate-Specific Antigen (PSA) Density and Free/Total PSA Ratio in Diagnosing Clinically Significant Prostate Cancer (PCa) in Patients with Histologically Confirmed PCa with a PSA Level of 2.5-10 Ng/ML." Üroonkoloji Bülteni 20.4 (2021).
2. Han, C., et al. "MRI combined with PSA density in detecting clinically significant prostate cancer in patients with PSA serum levels of 4∼ 10 ng/mL: Biparametric versus multiparametric MRI." Diagnostic and Interventional Imaging 101.4 (2020): 235-244
3. Fulgham, Pat F., et al. "AUA policy statement on the use of multiparametric magnetic resonance imaging in the diagnosis, staging and management of prostate cancer." The Journal of urology 198.4 (2017): 832-838.
4. Vũ Trung Kiên, Đỗ Trường Thành (2020). Đặc điểm lâm sàng, cận lâm sàng và yếu tố liên quan đến tiên lượng bệnh nhân ung thư tuyến tiền liệt được chẩn đoán qua sinh thiết 12 mẫu. Y học Việt Nam, tháng 1-Số 1&2/2020, tập 486, Tr. 163-16
5. Huynh, Dương Văn, and Dư Thị Ngọc Thu. "Đặc điểm lâm sàng, cận lâm sàng và kết quả sinh thiết tuyến tiền liệt trên bệnh nhân bướu tuyến tiền liệt có psa cao trên 4ng/ml." Tạp chí Y Dược học Cần Thơ 65 (2023): 226-233.
6. Hoàng , Đình Âu và Trương , T. T. . (2023) “Đánh giá các loại tổn thương điểm pi-rads ≥3 vùng chuyển tiếp tuyến tiền liệt theo phân loại pi-rads v2.1 nhằm phát hiện ung thư điểm gleason ≥7”, Tạp chí Y học Việt Nam, 532(2). doi: 10.51298/vmj.v532i2.7522.
7. Shan, J., Geng, X., Lu, Y., Liu, Z., Zhu, H., Zhou, R.,... & Shi, H. (2022). The influence of prostate volume on clinical parameters in prostate cancer screening. Journal of Clinical Laboratory Analysis, 36(10), e24700.
8. Erol, B., Gulpinar, M. T., Bozdogan, G., Ozkanli, S., Onem, K., Mungan, G.,... & Mungan, A. (2014). The cutoff level of free/total prostate specific antigen (f/t PSA) ratios in the diagnosis of prostate cancer: a validation study on a Turkish patient population in different age categories. The Kaohsiung journal of medical sciences, 30(11), 545-550.
9. Rathnakumr, Geeta, Nitin Inamdar, and Kinjalka Ghosh. "Role of Free/Total Psa Ratio to Differentiate Bph and Prostate Cancer." Indian J. Sci. Res 10.1 (2019): 187-194.
10. Yilmaz, Enis C., et al. "Prospective Evaluation of PI-RADS Version 2.1 for Prostate Cancer Detection and Investigation of Multiparametric MRI–derived Markers." Radiology 307.4 (2023): e221309.